JSPR FY 2024 Earnings — Jasper Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

JSPRJasper Therapeutics, Inc.

$23M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$76M

Net Income

-$71M

EPS (Diluted)

$-4.89

Cash Flow

Operating Cash Flow

-$63M

Free Cash Flow

-$63M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$80M

Total Liabilities

$18M

Stockholders' Equity

$62M

Cash & Equivalents

$72M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$76M	-$69M	-10.7%
Net Income	-$71M	-$64M	-10.6%